4//SEC Filing
Silver Ronald 4
Accession 0001209191-22-014661
CIK 0001446847other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:01 PM ET
Size
8.9 KB
Accession
0001209191-22-014661
Insider Transaction Report
Form 4
Silver Ronald
Principal Accounting Officer
Transactions
- Sale
Class A Common Stock
2022-02-28$10.77/sh−448$4,825→ 63,001 total - Sale
Class A Common Stock
2022-02-28$10.77/sh−640$6,893→ 62,361 total - Sale
Class A Common Stock
2022-02-28$10.77/sh−1,150$12,386→ 61,211 total
Footnotes (4)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 29, 2019.
- [F2]The reporting person acquired 2,236 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2021.
- [F3]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 27, 2020.
- [F4]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February 23, 2021.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001873731
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:01 PM ET
- Size
- 8.9 KB